According to Benzinga Pro, Legend Biotech's peer group average for short interest as a percentage of float is 11.10%, which ...

Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any ...

Here are two stocks with buy rank and strong value characteristics for investors to consider today, April 23: Phio ...

BioLife Solutions, an established biotech firm ... to investors by a stock buyback or dividends to shareholders. At first glance, there are two visual outliers on the chart, the 2021 Revenue ...

Regeneron's oncology platform is poised to be a significant growth driver in the next decade. Read why REGN stock remains a Top Pick.

The downside comes after PCVX reports mixed results from a mid-stage study on its pneumococcal vaccine in infants.

Before we present a few biotech stocks that are well-positioned to beat the industry based on a strong ... as depicted in the chart below. Amicus Therapeutics’ lead drug Galafold has shown ...

Expert stock picks: Here are three stocks to buy, as recommended by Raja Venkatraman of NeoTrader, for Wednesday, 23 April.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Tariffs. Trade Wars. Chaos. Here's 1 Go-To Warren Buffett Dividend King Stock That's Built for Storms.

In 2024, biotechnology companies ... as shown in the chart below. Sidley’s 11th annual survey of Securities Class Actions in the Life Science Sector 1 provides in-depth analyses of the appellate ...